NCT06929650View on ClinicalTrials.gov

The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 20, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Thyroid NoduleThyroid Cancer
Interventions
PROCEDURE

Radiofrequency ablation

"Radiofrequency energy is delivered to the thyroid nodule via the medical device. This device is a system consisting of 3 main components:~1. VIVA combo RF system (generator and pump)~2. single foot switch~3. electrode (5mm, 7mm, 10mm, or adjustable)."

Trial Locations (1)

M5G2C4

RECRUITING

University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER